Literature DB >> 20033908

The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.

Michael Bauer1, Tasha Glenn, Paul Grof, Wendy Marsh, Kemal Sagduyu, Martin Alda, Greg Murray, Ute Lewitzka, Rita Schmid, Sara Haack, Peter C Whybrow.   

Abstract

OBJECTIVE: Multiple psychotropic medications are routinely prescribed to treat bipolar disorder, creating complex medication regimens. This study investigated whether the daily number of psychotropic medications or the daily number of pills were associated with self-reported adherence with taking a mood stabilizer.
METHODS: Patients self-reported their mood and medications taken daily for about 6 months. Adherence was defined as taking at least one pill of any mood stabilizer daily. Univariate general linear models (GLMs) were used to estimate if adherence was associated with the number of daily medications and the number of pills, controlling for age. The association between mean daily dosage of mood stabilizer and adherence was also estimated using a GLM.
RESULTS: Three hundred and twelve patients (mean age 38.4 +/- 10.9 years) returned 58,106 days of data and took a mean of 3.1 +/- 1.6 psychotropic medications daily (7.0 +/- 4.2 pills). No significant association was found between either the daily number of medications or the daily number of pills and adherence. For most mood stabilizers, patients with lower adherence took a significantly smaller mean daily dosage.
CONCLUSIONS: The number of concurrent psychotropic medications may not be associated with adherence in bipolar disorder. Patients with lower adherence may be taking smaller dosages of mood stabilizers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20033908     DOI: 10.1002/hup.1077

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  7 in total

1.  Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey.

Authors:  John A Bates; Richard Whitehead; Susan C Bolge; Edward Kim
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Is cognitive behaviour therapy applicable to individuals diagnosed with bipolar depression or suboptimal mood stabilizer treatment: a secondary analysis of a large pragmatic effectiveness trial.

Authors:  Jan Scott; Richard Bentall; Peter Kinderman; Richard Morriss
Journal:  Int J Bipolar Disord       Date:  2022-05-03

3.  Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.

Authors:  Michael Bauer; Tasha Glenn; Martin Alda; Kemal Sagduyu; Wendy Marsh; Paul Grof; Rodrigo Munoz; Emanuel Severus; Philipp Ritter; Peter C Whybrow
Journal:  Int J Bipolar Disord       Date:  2013-05-03

Review 4.  Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.

Authors:  Michele Fornaro; Domenico De Berardis; Ann Sarah Koshy; Giampaolo Perna; Alessandro Valchera; Davy Vancampfort; Brendon Stubbs
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-31       Impact factor: 2.570

Review 5.  Electronic monitoring of self-reported mood: the return of the subjective?

Authors:  Abigail Ortiz; Paul Grof
Journal:  Int J Bipolar Disord       Date:  2016-11-29

Review 6.  Systematic review of patients' participation in and experiences of technology-based monitoring of mental health symptoms in the community.

Authors:  Sophie Walsh; Eoin Golden; Stefan Priebe
Journal:  BMJ Open       Date:  2016-06-21       Impact factor: 2.692

7.  Trajectories of adherence to mood stabilizers in patients with bipolar disorder.

Authors:  M Bauer; T Glenn; M Alda; R Bauer; P Grof; W Marsh; S Monteith; R Munoz; N Rasgon; K Sagduyu; P C Whybrow
Journal:  Int J Bipolar Disord       Date:  2019-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.